Brief: Orexo's Adrenaline Product Ox640 Receives First European Patent

Orexo AB

01/09/2022 07:06

Sept 1 (Reuters) - Orexo AB  ORX.ST :
    * FIRST PATENT ISSUED IN EUROPE FOR OREXO'S ADRENALINE
PRODUCT
OX640
    * TODAY ANNOUNCES THAT EUROPEAN PATENT OFFICE (EPO) HAS
GRANTED
FIRST EUROPEAN PATENT SPECIFICALLY RELATING TO OX640, OREXO'S
NASAL ADRENALINE RESCUE MEDICATION BASED ON THEAMORPHOX®DRUG
DELIVERY PLATFORM
    * NEW PATENT, EP 3 962 455 B1, PROVIDES PROTECTION FOR OX640
PRODUCT IN EUROPE UNTIL MAY 2041
    * OREXO HAS MULTIPLE PATENT APPLICATIONS FILED IN OTHER
TERRITORIES AND EXPECT TO CONTINUOUSLY STRENGTHEN PATENT
PORTFOLIO FOR OX640

Source text for Eikon:  ID:nWkrm2y8y 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))